Video Latest - ecancer

Firstline pembrolizumab plus chemo improves NSCLC outcomes

Dr Corey Langer - University of Pennsylvania, Philadelphia, USA

9 Oct 2016

Firstline pembrolizumab for metastatic urothelial cancer

Dr Arjun Balar - NYU Langone Medical Center, New York, USA

9 Oct 2016

Dabrafenib shows higher response and lower toxicity in paediatric brain cancer trial

Dr Mark Kieran - Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, USA

8 Oct 2016

Outcome of ovarian cancer patients was significantly improved with niraparib

Dr Mansoor Raza Mirza - Copenhagen University Hospital, Copenhagen, Denmark

8 Oct 2016

Ipilimumab as adjuvant therapy improves OS in high risk melanoma

Prof Alexander Eggermont - Institut Gustave Roussy, Villejuif, France

8 Oct 2016

Ribociclib improves PFS for postmenopausal women with hormone receptor-positive breast cancer

Dr Gabriel Hortobagyi - MD Anderson, Houston, USA

8 Oct 2016

Immunotherapy and treatment advances in small cell lung cancer

Prof Dean Fennell - University of Leicester, Leicester, UK

6 Oct 2016

Combining drugs with radiotherapy

Prof John Staffurth - Cardiff University, Cardiff, UK

5 Oct 2016

A novel biomarker for paediatic tumours

Dr Kathleen Birley - UCL Institute of Child Health, London, UK

5 Oct 2016

NSCLC biology and new therapies: Immunotherapies

Dr Rafael Rosell - Catalan Institute of Oncology, Barcelona, Spain

5 Oct 2016

Immunotherapy in lung cancer: Q & A

Prof Giuseppe Giaccone and Dr Olivier Pardo

5 Oct 2016

Immunotherapy in NSCLC

Prof Giuseppe Giaccone - Georgetown University, Washington DC, USA

5 Oct 2016

Video